Strategic Initiative
Slingshot members are tracking this corporate initiative:
Dermavant Sciences Licenses Portola's (PTLA) Cerdulatinib for Topical Non-Cancer Applications
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| PTLA |
|
|
Dermavant Sciences |
|
|
|
Slingshot Insights Explained
Strategic Initiative Date
Announcement Date: Dec 21, 2016 Projected Implementation: Q1, 2017 Relevance Tracked Until: Q1, 2019
Related Projects
-
Don’t see a project related to the strategic initiative you care about?
Related Keywords
License Agreement, Cerdulatinib, Topical, Non-cancer Applications
